IKE Tech and Charlie's Holdings Partner For FIRST U.S. Vape Age Gating System

IKE Tech and Charlie’s Holdings (OTCQB: CHUC) Leapfrog Big Tobacco with Age Gating solution

Summary:

Continuous age verification, combined with SBX, a nicotine-analogue flavored vape that is legal in almost all 50 states, disrupts the $8B industry, giving both companies a first-mover advantage over Big Tobacco.

CHUC’s 650 PMTA product portfolio, with an imputed value of more than $650M, looks even more valuable now… We’ll explain why.

The Reason for CHUC Insider Buying?

Dr. Ed Carmines, known for his PMTA expertise, is a CHUC Independent Director and also serves as Chief Scientific Officer at Chemular. 

IKE Tech LLC is a joint venture company formed by Chemular Inc, Ispire Technology Inc., and Touch Point Worldwide Inc. (d/b/a Berify).

We think we now understand why Ed (and other members of mgmt) have been buying CHUC shares on the open market, as recently as last week.

IKE Tech’s patented age-gating technology is considered superior to all other technologies in development because IKE’s technology continuously verifies age at the point of use, not just at the time of purchase. The vaper’s phone must be within Bluetooth range of the device when in use.

THAT is a key thing the FDA is demanding.

IKE Tech submitted a Premarket Tobacco Product Application (PMTA) and a Tobacco Product Master File (TPMF) to the FDA on May 1, 2025, for its standalone, interoperable, blockchain-based age-gating system.

IKE received an Acceptance Review letter from the FDA for its PMTA, just one month after submission.

That’s incredible news… there’s just one problem: even if they get FDA approval, IKE still needs an actual flavored nicotine vape product to employ with its technology in order to validate efficacy.

Age-gating a tobacco-flavored vape, is pointless. Adults don’t want them, and neither do kids.

That’s where CHUC’s SBX comes in.

IKE Tech and CHUC Partnership A Huge Win Win for BOTH Companies

SBX provides adult consumers with the same satisfaction that typical nicotine disposables provide… but without nicotine.  Because SBX does not consist of or contain nicotine from any source, SBX is not subject to FDA PMTA requirements.

SO… SBX with IKE’s age-gating technology, allows IKE (and CHUC) to enter the space BEFORE and WITHOUT the burdensome, lengthy FDA PMTA review process.

CHUC’s SBX gives IKE first-mover advantage.

The demand for SBX is through the roof. Q3 revenue was up 330% and Q4 is expected to be up as much as 450%. Charlie’s has increased projections twice in the last 60 days and feels the Company could be on a $120MM annual run rate by mid 2026.

Here’s what IKE Tech gets:

1. A flavored vape product that employs their age-gating technology.
2. Revenue WITHOUT the burdensome, lengthy FDA PMTA review process and BEFORE Big Tobacco players have an age-gating solution authorized for sale.
3. Real consumer market data to submit to FDA.
4. First mover advantage for an age-gating solution with a flavored vape product.

Here’s what CHUC gets:

1. First mover-advantage will gve the company a competitive advantage with the compliance-minded national c-store chains.
2. SBX consumer test market data should make CHUC’s 650 PMTAs (for nicotine products) A LOT MORE valuable than the $1M per SKU that one Big Tobacco company paid in CHUC’s last PMTA sale.
3. Age-gated nicotine products, with sales across the US could be the spark that ignites a Big Tobacco buyout.

Right now, Big Tobacco can only sit and watch as CHUC launches its highly popular flavored SBX vape, enhanced with age-gating technology …but

Remember how Big Tobacco was buying and licensing a tiny, tiny fraction of CHUC’s PMTAs over the Summer? 

The last one sold for $1MM… and CHUC has more than 650 left!, 

We think the value per PMTA (and CHUC) could explode if Ryan and Henry decide to amend those PMTAs to include IKE’s age-gating technology.

See how this is a massive win-win for both companies?

And…if the FDA or MAHA even hint about mandating age gating technology with nicotine products..we’ll let YOU imagine what CHUC could be worth.

Other Articles About Charlie’s Holdings OTCQB:CHUC

• OTCQB:CHUC Best Nicotine Vape Stock
• Best Profitable Penny Stock for 2026
• Big Tobacco Quietly Acquires CHUC PMTAs
• OTCQB:CHUC Investor Deck
• CHUC’s Latest Shareholder Letter
• Charlie’s Holdings OTCQB: CHUC Oct 2025 Interview
• CHUC Launches SBX Product Delivers 336% Q3 Revenue Growth
• BEST Profitable Penny Stock With Insider Buying

Safe Harbor Statement: This interview contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to statements regarding the Company’s overall business, existing and anticipated markets and expectations regarding future sales and expenses. Words such as “expect,” “anticipate,” “should,” “believe,” “target,” “project,” “goals,” “estimate,” “potential,” “predict,” “may,” “will,” “could,” “intend,” variations of these terms or the negative of these terms, and similar expressions, are intended to identify these forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond the Company’s control. The Company’s actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to: the Company’s ongoing ability to quote its shares on the OTCQB; whether the Company will meet the requirements to up-list to a national securities exchange in the future; the Company’s ability to successfully increase sales and enter new markets; whether the Company’s PMTA’s for its nicotine-containing products will be authorized by the FDA, and the FDA’s decisions with respect to the Company’s future PMTA’s for nicotine products; the Company’s ability to manufacture and produce products for its customers; the Company’s ability to formulate new products; the acceptance of existing and future products; the complexity, expense and time associated with compliance with government rules and regulations affecting nicotine, synthetic nicotine, and products containing nicotine substitutes; litigation risks from the use of the Company’s products; risks of government regulations; the impact of competitive products; and the Company’s ability to maintain and enhance its brands, as well as other risk factors included in the Company’s most recent quarterly report on Form 10-Q, annual report on Form 10-K, and other SEC filings. These forward-looking statements are made as of the date of this interview and are based on current expectations, estimates, forecasts and projections as well as the beliefs and assumptions of management. Except as required by law, the Company undertakes no duty or obligation to update any forward-looking statements contained in this interview as a result of new information, future events or changes in its expectations.

Artificial Intelligence Stock Reading

• The Best Artificial Intelligence Penny Stock VERSES AI
• Artificial Intelligence Stock with BIGGEST Potential
• What is BETTER than ChatGPT Generative Artificial Intelligence
• Generative Artificial Intelligence Regulation Solution
• How To Govern and Regulate Artificial Intelligence
• The BEST C3 AI Stock Alternative
• Next Generation Intelligence Patent Application
• The ONLY Adaptive Artificial Intelligence Stock
• Artificial Intelligence Stocks
• VERSES VRSSF 2023 Year End Summary
• The Story of VERSES AI VRSSF
• How VERSES AI Solves the Generative AI Problem